Stop TB Partnership

TB Drug Access Atlas Coming in November

Advance Access & Delivery (AA&D) and the Lilly MDR-TB Partnership are pleased to announce the launch of the TB Drug Access Atlas, an interactive, web-based tool for mapping the supply and access of quality-assured, second-line drugs for MDR-TB. This tool presents the burden of MDR-TB at the global and country levels, and highlights work currently being done or planned around the following seven market indicators: affordability, delivery challenges, forecasting, market incentives, procurement, regimen complexity and regulatory complexity.

The purpose of this tool is to provide data to inform decision-making, understand programmatic overlaps and take advantage of shared strengths. This tool is meant to encourage dialogue and spur momentum toward getting patients the drugs they need.

The TB Drug Access Atlas presents data and information about activities ongoing or planned for 2014-2020 and is organized by market indicator and geography. All information presented on this site was rigorously and systematically collected through a combination of desk research, surveys and telephone interviews.

The TB Drug Access Atlas will be available in November 2017. To learn more about this interactive website and upcoming tutorial, email